rs10865541

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4

The NM_016030.6(TRAPPC12):​c.681T>A​(p.Phe227Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000934 in 1,606,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F227S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000076 ( 0 hom. )

Consequence

TRAPPC12
NM_016030.6 missense

Scores

2
5
12

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.72

Publications

26 publications found
Variant links:
Genes affected
TRAPPC12 (HGNC:24284): (trafficking protein particle complex subunit 12) Involved in several processes, including endoplasmic reticulum to Golgi vesicle-mediated transport; positive regulation of protein localization to kinetochore; and regulation of kinetochore assembly. Located in Golgi apparatus; kinetochore; and nucleoplasm. Part of TRAPP complex. Colocalizes with endoplasmic reticulum-Golgi intermediate compartment and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
TRAPPC12 Gene-Disease associations (from GenCC):
  • early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.2925405).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRAPPC12NM_016030.6 linkc.681T>A p.Phe227Leu missense_variant Exon 2 of 12 ENST00000324266.10 NP_057114.5 Q8WVT3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRAPPC12ENST00000324266.10 linkc.681T>A p.Phe227Leu missense_variant Exon 2 of 12 1 NM_016030.6 ENSP00000324318.5 Q8WVT3
TRAPPC12ENST00000382110.6 linkc.681T>A p.Phe227Leu missense_variant Exon 2 of 12 2 ENSP00000371544.2 Q8WVT3
TRAPPC12ENST00000411973.3 linkn.177T>A non_coding_transcript_exon_variant Exon 1 of 4 5 ENSP00000405626.1 H7C2F7
TRAPPC12ENST00000482645.1 linkn.842T>A non_coding_transcript_exon_variant Exon 2 of 2 2

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
151852
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000297
AC:
7
AN:
235766
AF XY:
0.0000312
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000756
AC:
11
AN:
1454836
Hom.:
0
Cov.:
62
AF XY:
0.00000829
AC XY:
6
AN XY:
723756
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32246
American (AMR)
AF:
0.00
AC:
0
AN:
44276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25880
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39002
South Asian (SAS)
AF:
0.000129
AC:
11
AN:
85512
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52820
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5734
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1109256
Other (OTH)
AF:
0.00
AC:
0
AN:
60110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
151960
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41484
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5100
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67900
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
ExAC
AF:
0.0000415
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome Uncertain:1
Jun 22, 2023
Neuberg Centre For Genomic Medicine, NCGM
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The observed missense variant c.681T>A(p.Phe227Leu) in the TRAPPC12 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. A different missense variant [c.679T>G (p.Phe227Val)] at the same position has been reported in homozygous state in an affected individual (Aslanger AD, et al., 2020). This variant is reported with the allele frequency 0.003% in the gnomAD Exomes. The amino acid Phe at position 227 is changed to a Leu changing protein sequence and it might alter its composition and physico-chemical properties. Multiple lines of computational evidence (Polyphen - Damaging, SIFT - Damaging and MutationTaster - Disease causing) predict a damaging effect on protein structure and function for this variant. The residue is conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. -

not provided Uncertain:1
Jun 01, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.96
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.014
T;T
Eigen
Benign
0.13
Eigen_PC
Benign
0.040
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.87
.;D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.29
T;T
MetaSVM
Benign
-0.53
T
MutationAssessor
Benign
1.9
L;L
PhyloP100
1.7
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
-2.1
N;N
REVEL
Benign
0.27
Sift
Uncertain
0.013
D;D
Sift4G
Benign
0.085
T;T
Polyphen
1.0
D;D
Vest4
0.60
MutPred
0.11
Gain of glycosylation at T229 (P = 0.1087);Gain of glycosylation at T229 (P = 0.1087);
MVP
0.62
MPC
0.96
ClinPred
0.44
T
GERP RS
3.3
Varity_R
0.21
gMVP
0.43
Mutation Taster
=63/37
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10865541; hg19: chr2-3392075; API